Manuel Baca
37Patents
10h-index
66Co-inventors
78Inventor score
Filing activity: Aug 6, 1997 → Oct 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6884879B1 | Anti-VEGF antibodies | Chemistry; Metallurgy | 319 | Expired |
| US7060269B1 | Anti-VEGF antibodies | Chemistry; Metallurgy | 159 | Expired |
| US7169901B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 94 | Expired |
| US7365166B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 73 | Active |
| US7297334B2 | Anti-vegf antibodies | Chemistry; Metallurgy | 62 | Expired |
| US7375193B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 44 | Active |
| US8182814B2 | Methods of treating inflammatory airway conditions by inhibition of IL-11 activity | Chemistry; Metallurgy | 22 | Active |
| US7993637B2 | IL-11 muteins | Human Necessities | 19 | Active |
| US8540977B2 | IL-11 muteins | Human Necessities | 18 | Active |
| US11124582B2 | FLT3L-FC fusion proteins | Chemistry; Metallurgy | 16 | Active |
| US7754213B2 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Chemistry; Metallurgy | 7 | Active |
| US10000553B2 | CD40L-specific TN3-derived scaffolds and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US9193793B2 | Antibodies against G-CSFR and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8568722B2 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Chemistry; Metallurgy | 2 | Active |
| US7919471B2 | Method of modulating cell survival and reagents useful for same | Human Necessities | 2 | Active |
| US8633297B2 | Protein scaffolds | Chemistry; Metallurgy | 2 | Active |
| US7785590B2 | Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1) | Chemistry; Metallurgy | 2 | Active |
| US8221755B2 | Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1) | Chemistry; Metallurgy | 2 | Active |
| US7683213B2 | Oxidation of propane to give acrylic acid using catalysts in a mixture of crystalline phases | Performing Operations; Transporting | 2 | Active |
| US9371388B2 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Chemistry; Metallurgy | 2 | Active |
| US8613925B2 | Anti-IL-13Rα1 antibodies and their uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7256007B2 | Methods of regulating cytokine signalling | Human Necessities | 1 | Expired |
| US9777062B2 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Chemistry; Metallurgy | 1 | Active |
| US9176129B2 | Protein scaffolds | Chemistry; Metallurgy | 1 | Active |
| US9212231B2 | TRAIL R2-specific multimeric scaffolds | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.